Beneficial effects of IL-4 and IL-6 on rat neonatal target cardiac cells (2020)
- Authors:
- USP affiliated authors: BYDLOWSKI, SERGIO PAULO - FM ; KRIEGER, JOSE EDUARDO - FM
- Unidade: FM
- DOI: 10.1038/s41598-020-69413-0
- Subjects: ANIMAIS; CÉLULAS ENDOTELIAIS; INTERLEUCINA 4; INTERLEUCINA 6; MACRÓFAGOS; MIOCÁRDIO; RATOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Scientific reports
- ISSN: 2045-2322
- Volume/Número/Paginação/Ano: v. 10, n. 1, article ID 12350, 12p, 2020
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
ZOGBI, Camila et al. Beneficial effects of IL-4 and IL-6 on rat neonatal target cardiac cells. Scientific reports, v. 10, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-69413-0. Acesso em: 10 jan. 2026. -
APA
Zogbi, C., Oliveira, N. C., Levy, D., Bydlowski, S. P., Bassaneze, V., Neri, E. A., & Krieger, J. E. (2020). Beneficial effects of IL-4 and IL-6 on rat neonatal target cardiac cells. Scientific reports, 10( 1). doi:10.1038/s41598-020-69413-0 -
NLM
Zogbi C, Oliveira NC, Levy D, Bydlowski SP, Bassaneze V, Neri EA, Krieger JE. Beneficial effects of IL-4 and IL-6 on rat neonatal target cardiac cells [Internet]. Scientific reports. 2020 ; 10( 1):[citado 2026 jan. 10 ] Available from: https://doi.org/10.1038/s41598-020-69413-0 -
Vancouver
Zogbi C, Oliveira NC, Levy D, Bydlowski SP, Bassaneze V, Neri EA, Krieger JE. Beneficial effects of IL-4 and IL-6 on rat neonatal target cardiac cells [Internet]. Scientific reports. 2020 ; 10( 1):[citado 2026 jan. 10 ] Available from: https://doi.org/10.1038/s41598-020-69413-0 - Multicellular regulation of miR-196a-5p and miR-425-5 from adipose stem cell-derived exosomes and cardiac repair
- Gametic phase disequilibrium between the syntenic multiallelic HTG4 and HMS3 markers widely used for parentage testing in Thoroughbred horses
- The effect of sildenafil in the multimeric composition of plasma von Willebrand factor in pulmonary hypertension: preliminary study
- Comment on: Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years
- Incidence of heparin-induced thrombocytopenia type II and relationship with anti-heparin/PF4 antibody
- Flow-dependent Cardiac Dysfunction and Pressure-dependent Endothelial Activation in Patients With Atrial Septal Defect
- Age-dependent likelihood o In Situ thrombosis in secondary pulmonary hypertension
- Detection of lung resistance-related protein (LRP) expression by RT-PCR in dogs with multicentric lymphoma
- Frequency of the mutations factor V leiden and prothrombin G20210A in patients with diagnosis of heparin induced thrombocytopenia
- Plasma von willebrand factor antigen as an independent risk factor for death in pulmonary arterial hypertension associated with congenital heart disease
Informações sobre o DOI: 10.1038/s41598-020-69413-0 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
